Preparation and antibacterial activity evaluation of 18-β-glycyrrhetinic acid loaded PLGA nanoparticles

Iranian Journal of Pharmaceutical Research

Volumn 14, Issue 2, 2015, Pages 373-383

  Darvishi, Behrad ^a   Manoochehri, Saeed ^a   Kamalinia, Golnaz ^a   Samadi, Nasrin ^a   Amini, Mohsen ^a   Mostafavi, Seyyed Hossein ^a   Maghazei, Shahab ^a   Atyabi, Fatemeh ^a   Dinarvand, Rassoul ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

18 glycyrrhetinic acid; Antibacterial activity; Nanoparticle; P. aeuroginosa; PLGA; S. aureus; S. epidermidis

Indexed keywords

18ALPHA GLYCYRRHETINIC ACID; NANOPARTICLE; POLYGLACTIN;

ANALYTICAL PARAMETERS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; ENCAPSULATION EFFICIENCY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PEPTONIPHILUS ASACCHAROLYTICUS; PHYSICAL CHEMISTRY; POLYDISPERSITY INDEX; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROPERTY; ZETA POTENTIAL;

EID: 84922996719     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fattal E, Rojas J, Youssef M, Couvreur P and Andremont A. Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrob. Agents Chemother. (1991) 35: 770-772.
2. Couvreur P, Fattal E and Andremont A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm. Res. (1991) 8: 1079-1086.
3. Gulyaev A, Ermekbaeva B, Kivman GY, Radchenko T, Sherstov AY and Shirinskii V. Nanoparticles as a vector for the directed delivery of antibiotics (a review). Pharm. Chem. J. (1998) 32: 115-118.
4. Koopaei MN, Khoshayand MR, Mostafavi SH, Amini M, Khorramizadeh MR, Tehrani MJ, Atyabi F and Dinarvand R. Docetaxel loaded PEG-PLGA nanoparticles: optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect. Iran. J. Pharm. Res. (2014) 13: 819.
5. Lutwyche P, Cordeiro C, Wiseman DJ, St-Louis M, Uh M, Hope MJ, Webb MS and Finlay BB. Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob. Agents Chemother. (1998) 42: 2511-2520.
6. Mohammadi G, Valizadeh H, Barzegar-Jalali M, Lotfpour F, Adibkia K, Milani M, Azhdarzadeh M, Kiafar F and Nokhodchi A. Development of azithromycin–PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids Surf B Biointerfaces (2010) 80: 34-39.
7. Fattal E, Youssef M, Couvreur P and Andremont A. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob. Agents Chemother. (1989) 33: 1540-1543.
8. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A and Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J. Control Release (2012) 161: 505-522.
9. Manoochehri S, Darvishi B, Kamalinia G, Amini M, Fallah M, Ostad SN, Atyabi F and Dinarvand R. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Daru (2013) 21: 1-10.
10. Abdollahi S and Lotfpour F. PLGA-and PLA-based polymeric nanoparticles for antimicrobial drug delivery. Biomed. Int. (2012) 3.
11. Amjadi I, Rabiee M and Hosseini M-S. Anticancer activity of nanoparticles based on PLGA and its co-polymer: in-vitro evaluation. Iran. J. Pharm. Res. (2013) 12: 623.
12. Mukerjee A and Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. (2009) 29: 3867-3875.
13. Zhang L, Pornpattananangkul D, Hu C-M and Huang C-M. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. (2010) 17: 585-594.
14. Salari M, Eshraghi S and Noroozi M. Antibacterial effect of glycyrrhetinic acid on 55 hospital strains of staphylococcus aureus and 32 actinobacillus actinomycetemcomitans. Daru (2001) 9: 2231.
15. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H and Doerr H. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (2003) 361: 2045-2046.
16. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, Hennessy EJ, Ezekowitz RAB and Moore KJ. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. (2005) 170: 477-485.
17. Baughn R and Bonventre PF. Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect. Immun. (1975) 12: 346-352.
18. Bayles KW, Wesson CA, Liou LE, Fox LK, Bohach GA and Trumble W. Intracellular staphylococcus aureusescapes the endosome and induces apoptosis in epithelial cells. Infect. Immun. (1998) 66: 336-342.
19. Oviedo-Boyso J, Bravo-Patiño A, Cajero-Juárez M, Valdez-Alarcón JJ and Baizabal-Aguirre VM. TNF-α reduces the level of Staphylococcus epidermidis internalization by bovine endothelial cells. FEMS Microbiol. Lett. (2009) 292: 92-99.
20. Mahenthiralingam E and Speert DP. Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial fagellum. Infect. Immun. (1995) 63: 4519-4523.
21. Alexopoulos A, Kimbaris A, Plessas S, Mantzourani I, Theodoridou I, Stavropoulou E, Polissiou M and Bezirtzoglou E. Antibacterial activities of essential oils from eight Greek aromatic plants against clinical isolates of Staphylococcus aureus. Anaerobe. (2011) 17: 399-402.
22. Reiter KC, Sant’Anna FH and d’Azevedo PA. Upregulation of icaA, atlE and aap genes by linezolid but not vancomycin in Staphylococcus epidermidis RP62A biofilms. Int. J. Antimicrob. Agents (2013) 43: 248-253
23. Carmeli Y, Troillet N, Eliopoulos GM and Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother. (1999) 43: 1379-1382.
24. Adibkia K, Omidi Y, Siahi MR, Javadzadeh AR, Barzegar-Jalali M, Barar J, Maleki N, Mohammadi G and Nokhodchi A. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J. Ocul. Pharmacol. Ther. (2007) 23: 421-432.
25. Kashi TSJ, Eskandarion S, Esfandyari-Manesh M, Marashi SMA, Samadi N, Fatemi SM, Atyabi F, Eshraghi S and Dinarvand R. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int. J. Nanomed. (2012) 7: 221.
26. Mainardes RM and Evangelista RC. 'PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int. J. Pharm. (2005) 290: 137-144.
27. Rafati H, Coombes A, Adler J, Holland J and Davis S. Protein-loaded poly (DL-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J. Control Release (1997) 43: 89-102.
28. Bodmeier R and McGinity J. Solvent selection in the preparation of poly (DL-lactide) microspheres prepared by the solvent evaporation method. Int. J. Pharm. (1988) 43: 179-186.
29. Shah N, Chaudhari K, Dantuluri P, Murthy R and Das S. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic® P85, an in vitro cell line and in vivo biodistribution studies on rat model. J. Drug Target. (2009) 17: 533-542.
30. Ahsan F, Rivas IP, Khan MA and Torres Suárez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. J. Control Release (2002) 79: 29-40.
31. Lu W, Wan J, She Z and Jiang X. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J. Control Release (2007) 118: 38-53.
32. Mo Y and Lim L-Y. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J. Control Release (2005) 108: 244-262.
33. Jelvehgari M, Nokhodchi A, Rezapour M and Valizadeh H. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Indian J. Pharm. Sci. (2010) 72: 8.
34. Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini M-A, Adibkia K and Nokhodchi A. Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev. Ind. Pharm. (2007) 33: 45-56.
35. Luan X, Skupin M, Siepmann J and Bodmeier R. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly (lactide-co-glycolide) microparticles. Int. J. Pharm. (2006) 324: 168-175.
36. Wang J, Wang BM and Schwendeman SP. Characterization of the initial burst release of a model peptide from poly (D, L-lactide-co-glycolide) microspheres. J. Control Release (2002) 82: 289-307.
37. Fonseca C, Simoes S and Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J. Control Release (2002) 83: 273-286.
38. Das S, Suresh PK and Desmukh R. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomed. Nanotech. Biol. Med. (2010) 6: 318-323.
39. Mishra B, Patel BB and Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed. Nanotech. Biol. Med. (2010) 6: 9-24.